Your browser doesn't support javascript.
loading
IFN-α in advanced well-differentiated neuroendocrine tumors: the neglected drug?
Amoroso, Vito; Pavel, Marianne; Claps, Melanie; Roca, Elisa; Ravanelli, Marco; Maroldi, Roberto; Oberg, Kjell; Berruti, Alfredo.
Afiliação
  • Amoroso V; Department of Medical & Surgical Specialties, Radiological Sciences & Public Health, Medical Oncology Unit, University of Brescia at ASST Spedali Civili, Brescia 25123, Italy.
  • Pavel M; Department of Medicine, Division of Endocrinology, Friedrich Alexander University Erlangen-Nürnberg, Erlangen 91012, Germany.
  • Claps M; Department of Medical & Surgical Specialties, Radiological Sciences & Public Health, Medical Oncology Unit, University of Brescia at ASST Spedali Civili, Brescia 25123, Italy.
  • Roca E; Department of Medical & Surgical Specialties, Radiological Sciences & Public Health, Medical Oncology Unit, University of Brescia at ASST Spedali Civili, Brescia 25123, Italy.
  • Ravanelli M; Department of Medical & Surgical Specialties, Radiological Sciences & Public Health, Radiology Unit, University of Brescia at ASST Spedali Civili, Brescia 25123, Italy.
  • Maroldi R; Department of Medical & Surgical Specialties, Radiological Sciences & Public Health, Radiology Unit, University of Brescia at ASST Spedali Civili, Brescia 25123, Italy.
  • Oberg K; Department of Endocrine Oncology, Uppsala University Hospital, Uppsala S-751 85, Sweden.
  • Berruti A; Department of Medical & Surgical Specialties, Radiological Sciences & Public Health, Medical Oncology Unit, University of Brescia at ASST Spedali Civili, Brescia 25123, Italy.
Future Oncol ; 14(10): 897-899, 2018 04.
Article em En | MEDLINE | ID: mdl-29528242

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon-alfa / Tumores Neuroendócrinos Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: Future Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon-alfa / Tumores Neuroendócrinos Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: Future Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália